FLT3 and DNMT3A mutations in AML are associated with reduced survival, while the prognostic significance of NMP1 mutations depends on the presence or absence of an FLT3 mutation and its allelic ratio (47–52). Here, DNMT3A is linked to acute myeloid leukemia.